The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry
Open accessAbstract
The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and drug design in order to establish key drug-target interactions and fine-tune crucial drug-like properties. In this perspective, we highlight physicochemical and conformational properties of urea derivatives. We provide outlines of traditional reagents and chemical procedures for the preparation of ureas. Also, we discuss newly developed methodologies mainly aimed at overcoming safety issues associated with traditional synthesis. Finally, we provide a broad overview of urea-based medicinally relevant compounds, ranging from approved drugs to recent medicinal chemistry developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Hill, D. J., Mio, M. J., Prince, R. B., Hughes, T. S., & Moore, J. S. (2001) · Chemical Reviews · doi:10.1021/cr990120t · Cited by 2,239
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
(1997) · PubMed · Cited by 1,541
Medicinal chemical properties of successful central nervous system drugs
Pajouhesh, H., & Lenz, G. R. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.541 · Cited by 1,535
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Sawyers, C. (2004) · Nature · doi:10.1038/nature03095 · Cited by 1,165
(Thio)urea organocatalysis—What can be learnt from anion recognition?
Zhang, Z., & Schreiner, P. R. (2009) · Chemical Society Reviews · doi:10.1039/b801793j · Cited by 1,109
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Ratain, M. J., Eisen, T., Stadler, W. M., Flaherty, K. T., Kaye, S. B., Rosner, G. L., Gore, M., Desai, A. A., Patnaik, A., Xiong, H. Q., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6723 · Cited by 1,032
Peters-Golden, M., & Henderson, W. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071371 · Cited by 1,013
Yang, X.-J., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210599 · Cited by 940
BRAF Mutation in Papillary Thyroid Carcinoma
Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W. H., Ladenson, P. W., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.625 · Cited by 922
Control of microtubule organization and dynamics: Two ends in the limelight
Akhmanova, A., & Steinmetz, M. O. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4084 · Cited by 895
Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors
Lam, P. Y. S., Jadhav, P. K., Eyermann, C. J., Hodge, C. N., Ru, Y., Bacheler, L. T., Meek, J. L., Otto, M. J., Rayner, M. M., Wong, Y. N., et al. (1994) · Science · doi:10.1126/science.8278812 · Cited by 834
Organic Carbamates in Drug Design and Medicinal Chemistry
Ghosh, A. K., & Brindisi, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501371s · Cited by 739
Self-citationThe Raf/MEK/ERK pathway: new concepts of activation
Peyssonnaux, C., & Eychène, A. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01125-x · Cited by 735
Tafesh, A. M., & Weiguny, J. (1996) · Chemical Reviews · doi:10.1021/cr950083f · Cited by 733
Ishikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Intramolecular Hydrogen Bonding in Medicinal Chemistry
Kuhn, B., Mohr, P., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100087s · Cited by 571
Matsui, J., Yamamoto, Y., Funahashi, Y., Tsuruoka, A., Watanabe, T., Wakabayashi, T., Uenaka, T., & Asada, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23131 · Cited by 551
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
Ho, T. W., Ferrari, M. D., Dodick, D. W., Galet, V., Kost, J., Fan, X., Leibensperger, H., Froman, S., Assaid, C., Lines, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61626-8 · Cited by 531
Matsui, J., Funahashi, Y., Uenaka, T., Watanabe, T., Tsuruoka, A., & Asada, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5270 · Cited by 530
Linezolid: The First Oxazolidinone Antimicrobial
Moellering, R. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00015 · Cited by 455
The role of the medicinal chemist in drug discovery — then and now
Lombardino, J. G., & Lowe, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1523 · Cited by 452
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439
Shelton, J., Lu, X., Hollenbaugh, J. A., Cho, J. H., Amblard, F., & Schinazi, R. F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00209 · Cited by 409
Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development
Vu, B., Wovkulich, P., Pizzolato, G., Lovey, A., Ding, Q., Jiang, N., Liu, J.-J., Zhao, C., Glenn, K., Wen, Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000657 · Cited by 395
Kiss, B., Horváth, A., Némethy, Z., Schmidt, É., Laszlovszky, I., Bugovics, G., Fazekas, K., Hornok, K., Orosz, S., Gyertyán, I., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160432 · Cited by 367
Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance
Peserico, A., & Simone, C. (2011) · BioMed Research International · doi:10.1155/2011/371832 · Cited by 357
Results of the Phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia
Andreeff, M., Kelly, K. R., Yee, K., Assouline, S., Strair, R., Popplewell, L., Bowen, D., Martinelli, G., Drummond, M. W., Vyas, P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0481 · Cited by 352
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Regan, J., Breitfelder, S., Cirillo, P., Gilmore, T., Graham, A. G., Hickey, E., Klaus, B., Madwed, J., Moriak, M., Moss, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020057r · Cited by 348
MMDB and VAST+: tracking structural similarities between macromolecular complexes
Madej, T., Lanczycki, C. J., Zhang, D., Thiessen, P. A., Geer, R. C., Marchler-Bauer, A., & Bryant, S. H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1208 · Cited by 339
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Alex, A., Millan, D. S., Perez, M., Wakenhut, F., & Whitlock, G. A. (2011) · MedChemComm · doi:10.1039/c1md00093d · Cited by 329
Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 328
Linezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase
Moghaddam, M. F., Grant, D. F., Cheek, J. M., Greene, J. F., Williamson, K. C., & Hammock, B. D. (1997) · Nature Medicine · doi:10.1038/nm0597-562 · Cited by 309
Bifunctional primary amine-thioureas in asymmetric organocatalysis
Serdyuk, O. V., Heckel, C. M., & Tsogoeva, S. B. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41403e · Cited by 304
Oxidative Carbonylation as a Powerful Tool for the Direct Synthesis of Carbonylated Heterocycles
Gabriele, B., Mancuso, R., & Salerno, G. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201200794 · Cited by 290
Okamoto, K., Kodama, K., Takase, K., Sugi, N. H., Yamamoto, Y., Iwata, M., & Tsuruoka, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.007 · Cited by 288
Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir
Sevrioukova, I. F., & Poulos, T. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010693107 · Cited by 288
Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.
Okamoto, K., Ikemori-Kawada, M., Jestel, A., von König, K., Funahashi, Y., Matsushima, T., Tsuruoka, A., Inoue, A., & Matsui, J. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500394m · Cited by 285
The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs
Maxwell, A., & Lawson, D. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452500 · Cited by 277
The development of drugs for treatment of sleeping sickness: a historical review
Steverding, D. (2010) · Parasites & Vectors · doi:10.1186/1756-3305-3-15 · Cited by 274
DeAngelo, D. J., Stone, R. M., Heaney, M. L., Nimer, S. D., Paquette, R. L., Klisovic, R. B., Caligiuri, M. A., Cooper, M. R., Lecerf, J.-M., Karol, M. D., et al. (2006) · Blood · doi:10.1182/blood-2006-02-005702 · Cited by 272
Ueber künstliche Bildung des Harnstoffs
Wöhler, F. (1828) · Annalen der Physik · doi:10.1002/andp.18280880206 · Cited by 268
Structural Plasticity in Actin and Tubulin Polymer Dynamics
Kueh, H. Y., & Mitchison, T. J. (2009) · Science · doi:10.1126/science.1168823 · Cited by 266
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Ho, T. W., Connor, K. M., Zhang, Y., Pearlman, E., Koppenhaver, J., Fan, X., Lines, C., Edvinsson, L., Goadsby, P. J., & Michelson, D. (2014) · Neurology · doi:10.1212/wnl.0000000000000771 · Cited by 262
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler, H. G. (1996) · PubMed · Cited by 251
Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors
Hwang, S. H., Tsai, H.-J., Liu, J.-Y., Morisseau, C., & Hammock, B. D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070270t · Cited by 225
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
Lathia, C., Lettieri, J., Cihon, F., Gallentine, M., Radtke, M., & Sundaresan, P. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0068-6 · Cited by 212
Lenvatinib: Role in thyroid cancer and other solid tumors
Cabanillas, M. E., & Habra, M. A. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.11.003 · Cited by 208
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Johnson, D. S., Stiff, C., Lazerwith, S. E., Kesten, S. R., Fay, L. K., Morris, M., Beidler, D., Liimatta, M. B., Smith, S. E., Dudley, D. T., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100190t · Cited by 199
Chao, Q., Sprankle, K. G., Grotzfeld, R. M., Lai, A. G., Carter, T. A., Velasco, A. M., Gunawardane, R. N., Cramer, M. D., Gardner, M. F., James, J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9007533 · Cited by 198
Bergman, J. A., Woan, K., Perez-Villarroel, P., Villagra, A., Sotomayor, E. M., & Kozikowski, A. P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301098e · Cited by 195
D'Souza, D. C., Cortes-Briones, J., Creatura, G., Bluez, G., Thurnauer, H., Deaso, E., Bielen, K., Surti, T., Radhakrishnan, R., Gupta, A., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30427-9 · Cited by 195
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Barinka, C., Rojas, C., Slusher, B., & Pomper, M. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799034888 · Cited by 194
Carbonyldiimidazole-Mediated Lossen Rearrangement
Dubé, P., Nathel, N. F. F., Vetelino, M., Couturier, M., Aboussafy, C. L., Pichette, S., Jorgensen, M. L., & Hardink, M. (2009) · Organic Letters · doi:10.1021/ol9023387 · Cited by 190
The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis
Kim, H., & Muller, W. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4706 · Cited by 190
Synthesis of urea derivatives from amines and CO2 in the absence of catalyst and solvent
Wu, C., Cheng, H., Liu, R., Wang, Q., Hao, Y., Yu, Y., & Zhao, F. (2010) · Green Chemistry · doi:10.1039/c0gc00059k · Cited by 180
Getman, D. P., DeCrescenzo, G. A., Heintz, R. M., Reed, K. L., Talley, J. J., Bryant, M. L., Clare, M., Houseman, K. A., & Marr, J. J. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00054a014 · Cited by 179
Parallel Synthesis of Ureas and Carbamates from Amines and CO2 under Mild Conditions
Peterson, S. L., Stucka, S. M., & Dinsmore, C. J. (2010) · Organic Letters · doi:10.1021/ol100259j · Cited by 176
An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates
Nowick, J. S., Powell, N. A., Nguyen, T. M., & Noronha, G. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00052a069 · Cited by 163
A New Look at Lipid-Membrane Structure in Relation to Drug Research
Mouritsen, O. G., & Jørgensen, K. (1998) · Pharmaceutical Research · doi:10.1023/a:1011986613392 · Cited by 159
Structure-guided inhibitor design for human FAAH by interspecies active site conversion
Mileni, M., Johnson, D. S., Wang, Z., Everdeen, D. S., Liimatta, M. B., Pabst, B. A., Bhattacharya, K., Nugent, R. A., Kamtekar, S., Cravatt, B. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806121105 · Cited by 155
Claudon, P., Violette, A., Lamour, K., Décossas, M., Fournel, S., Heurtault, B., Godet, J., Mély, Y., Jamart‐Grégoire, B., Averlant‐Petit, M., et al. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200905591 · Cited by 155
Stability of folded conformations
Creighton, T. E. (1991) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(91)90004-d · Cited by 151
Hodge, C. N., Aldrich, P. E., Bacheler, L. T., Chang, C., Eyermann, C. J., Garber, S., Grubb, M. F., Jackson, D. A., Jadhav, P. K., Korant, B. D., et al. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90110-6 · Cited by 149
Peer, C. J., Sissung, T. M., Kim, A., Jain, L., Woo, S., Gardner, E. R., Kirkland, C. T., Troutman, S. M., English, B. C., Richardson, E. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2484 · Cited by 148
Citrome, L. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759211 · Cited by 134
Rossi, A., Pergola, C., Koeberle, A., Hoffmann, M., Dehm, F., Bramanti, P., Cuzzocrea, S., Werz, O., & Sautebin, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00930.x · Cited by 133
Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties
Hofmann, C., Penner, U., Dorow, R., Pertz, H. H., hnichen, S. J., HOROWSKI, R., Latt, K. P., Palla, D., & Schurad, B. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200603000-00005 · Cited by 106
Development And Strategies Of VEGFR-2/KDR Inhibitors
Huang, L., Huang, Z., Bai, Z., Xie, R., Sun, L., & Lin, K. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.121 · Cited by 103
Gomez, G. A., Morisseau, C. H. P., Hammock, B. D., & Christianson, D. W. (2005) · Protein Science · doi:10.1110/ps.051720206 · Cited by 101
Saxena, R., & Dwivedi, A. (2010) · Medicinal Research Reviews · doi:10.1002/med.20209 · Cited by 101
Zhang, H., Gong, F.-H., Ye, J.-Q., Zhang, C., Yue, X.-H., Li, C.-G., Xu, Y., & Sun, L. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.039 · Cited by 90
Henry, J. R., Kaufman, M. D., Peng, S.-B., Ahn, Y. M., Caldwell, T. M., Vogeti, L., Telikepalli, H., Lu, W.-P., Hood, M. M., Rutkoski, T. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00067 · Cited by 89
Brindisi, M., Maramai, S., Gemma, S., Brogi, S., Grillo, A., Di Cesare Mannelli, L., Gabellieri, E., Lamponi, S., Saponara, S., Gorelli, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01812 · Cited by 86
Self-citationPriyakumar, U. D., Hyeon, C., Thirumalai, D., & MacKerell, A. D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905795v · Cited by 85
A New Era of Hepatitis C Therapy Begins
Jensen, D. M. (2011) · New England Journal of Medicine · doi:10.1056/nejme1100829 · Cited by 77
Matzen, L., van Amsterdam, C., Rautenberg, W., Greiner, H. E., Harting, J., Seyfried, C. A., & Böttcher, H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9811054 · Cited by 74
X-Ray Structures of the LXRα LBD in Its Homodimeric Form and Implications for Heterodimer Signaling
Fradera, X., Vu, D., Nimz, O., Skene, R. J., Hosfield, D. J., Wynands, R., Cooke, A., Haunsø, A., King, A. W. T., Bennett, D. J., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.005 · Cited by 74
Vakana, E., Pratt, S. E., Blosser, W. D., Dowless, M. S., Simpson, N., Yuan, X., Jaken, S., Manro, J. R., Stephens, J. R., Zhang, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14002 · Cited by 74
Hussein, Z., Mizuo, H., Hayato, S., Namiki, M., & Shumaker, R. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0403-4 · Cited by 72
Goyal, S., Chattopadhyay, A., Kasavajhala, K., & Priyakumar, U. D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05463 · Cited by 69
Caccia, S., Invernizzi, R. W., Nobili, A., & Pasina, L. (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s35137 · Cited by 68
Ghosal, A., Yuan, Y., Tong, W., Su, A.-D., Gu, C., Chowdhury, S. K., Kishnani, N. S., & Alton, K. B. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036996 · Cited by 68
Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases
Tayade, P., Saraf, M. N., & Rajendrakumar, K. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021819 · Cited by 66
Hammill, J. T., Bhasin, D., Scott, D. C., Min, J., Chen, Y., Lü, Y., Yang, L., Kim, H. S., Connelly, M., Hammill, C. V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01282 · Cited by 66
Patnaik, A., Tolcher, A. W., Beeram, M., Nemunaitis, J. J., Weiss, G. J., Bhalla, K. N., Agrawal, M., NICHOLS, G. L., Middleton, S. A., Beryozkina, A., et al. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2830-8 · Cited by 64
Shibata, S., Gillespie, J. R., Ranade, R. M., Koh, C. Y., Kim, J. E., Laydbak, J. U., Zucker, F. H., Hol, W. G. J., Verlinde, C. L. M. J., C, F. S. B. A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300303e · Cited by 63
Patrick, D. A., Gillespie, J. R., McQueen, J., Hulverson, M. A., Ranade, R. M., Creason, S. A., Herbst, Z. M., Gelb, M. H., C, F. S. B. A., & Tidwell, R. R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01163 · Cited by 61
Zheng, S., Li, F., Liu, J., & Xia, C. (2007) · Tetrahedron Letters · doi:10.1016/j.tetlet.2007.06.049 · Cited by 61
Potential role of sorafenib in the treatment of acute myeloid leukemia
Mori, S., Cortes, J. E., Kantarjian, H. M., Zhang, W., Andreef, M., & Ravandi, F. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802510349 · Cited by 56
Kudo, M., Hanashima, T., Muranaka, A., Sato, H., Uchiyama, M., Azumaya, I., Hirano, T., Kagechika, H., & Tanatani, A. (2009) · The Journal of Organic Chemistry · doi:10.1021/jo901934r · Cited by 54
Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis
Tang, X., Mahajan, S. S., Nguyen, L. T., Béliveau, F., Leduc, R., Simon, J. A., & Vasioukhin, V. I. (2014) · Oncotarget · doi:10.18632/oncotarget.1817 · Cited by 53
Conformations of substituted arylureas in solution
LEPORE, G. C., Migdal, S., Blagdon, D. E., & Goodman, M. (1973) · The Journal of Organic Chemistry · doi:10.1021/jo00955a003 · Cited by 51
Mowafy, S., Farag, N. A., & Abouzid, K. A. M. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.017 · Cited by 49
Potential of aryl–urea–benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease
Kurt, B. Z., Gazioğlu, I., Basile, L., Sönmez, F., Ginex, T., Küçükislamoğlu, M., & Guccione, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.005 · Cited by 45
Linifanib: current status and future potential in cancer therapy
Aversa, C., Leone, F., Zucchini, G., Serini, G., Geuna, E., Milani, A., Valdembri, D., Martinello, R., & Montemurro, F. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1042369 · Cited by 42
Haydar, S. N., Ghiron, C., Bettinetti, L., Bothmann, H., Comery, T. A., Dunlop, J., Rosa, S. L., Micco, I., Pollastrini, M., Quinn, J., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.040 · Cited by 41
Azam, F., Alkskas, I. A., & Ahmed, M. A. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.04.007 · Cited by 40
Matsumura, M., Tanatani, A., Azumaya, I., Masu, H., Hashizume, D., Kagechika, H., Muranaka, A., & Uchiyama, M. (2012) · Chemical Communications · doi:10.1039/c2cc37583d · Cited by 39
Li, G., Ma, S., Yang, L., Ji, S., Fang, Z. Y., Zhang, G., Wang, L., Zhong, J., Xiong, Y., Wang, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00604 · Cited by 39
Elkamhawy, A., Lee, J., Park, B.-G., Park, I., Pae, A. N., & Roh, E. J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.027 · Cited by 38
Siddiqui, N., Alam, M. S., & Stables, J. P. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.004 · Cited by 36
Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
Cheng, A., Hsu, C., Shen, Y., Shao, Y., & Hsu, C. (2014) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s45040 · Cited by 35
Hoang, V.-H., Ngo, V. T. H., Cui, M., Mạnh, N. V., Tran, P., Ann, J., Ha, H.-J., Kim, H., Choi, K., Kim, Y.-H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00751 · Cited by 35
Ravez, S., Barczyk, A., Six, P., Cagnon, A., Garofalo, A., Goossens, L., & Depreux, P. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.007 · Cited by 34
Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases
Stokes, N. R., Thomaides-Brears, H. B., Barker, S., Bennett, J. M., Berry, J., Collins, I., Czaplewski, L. G., Gamble, V., Lancett, P., Logan, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-13 · Cited by 34
Schwartz, B. D., Skinner‐Adams, T. S., Andrews, K. T., Coster, M. J., Edstein, M. D., Mackenzie, D., Charman, S. A., Koltun, M., Blundell, S. A., Campbell, A., et al. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01849d · Cited by 32
Schnekenburger, M., Goffin, E., Lee, J., Jang, J. Y., Mazumder, A., Ji, S., Rogister, B., Bouider, N., Lefranc, F., Miklos, W., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00533 · Cited by 31
Nawarskas, J. J., Cheng-Lai, A., & Frishman, W. H. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000159 · Cited by 31
Ghiron, C., Haydar, S. N., Aschmies, S., Bothmann, H., Castaldo, C., Cocconcelli, G., Comery, T. A., Di, L., Dunlop, J., Lock, T., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901692q · Cited by 30
In Vitro Plasma Protein Binding of Zileuton and its N-Dehydroxylated Metabolite
Machinist, J. M., Kukulka, M. J., & Bopp, B. A. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199500292-00006 · Cited by 30
Zhang, X., Peng, T., Ji, X., Li, J., Tong, L., Li, Z., Yang, W., Xu, Y., Li, M., Ding, J., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.049 · Cited by 28
Nencini, A., Castaldo, C., Comery, T. A., Dunlop, J., Genesio, E., Ghiron, C., Haydar, S. N., Maccari, L., Micco, I., Turlizzi, E., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.031 · Cited by 21
Amato, R. J., Felts, A. S., Rodriguez, A. L., Venable, D. F., Morrison, R. D., Byers, F. W., Daniels, J. S., Niswender, C. M., Conn, P. J., Lindsley, C. W., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400070k · Cited by 20
Xu, H., Lu, H., Xu, Z., Luan, L., Li, C., Xu, Y., Dong, K., Zhang, J., Li, X., Li, Y., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00489 · Cited by 20
Gaiser, B. I., Danielsen, M., Märcher-Rørsted, E., Jørgensen, K. R., Wróbel, T. M., Frykman, M., Johansson, H., Bräuner‐Osborne, H., Gloriam, D. E. I., Mathiesen, J. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00595 · Cited by 20
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands
Subedi, M., Minn, I., Chen, J., Kim, Y., Ok, K., Jung, Y. W., Pomper, M. G., & Byun, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.033 · Cited by 19
Efficacy of Oral Anticancer Agents for Colorectal Cancer
Sakamoto, J., Oba, K., Matsui, T., & Kobayashi, M. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0601-7 · Cited by 15
Yan, H., Li, W., Zhang, Y., Wei, X., Fu, L., Shen, G., Yin, T., Li, X., Shi, H., Wan, Y., et al. (2014) · Immunologic Research · doi:10.1007/s12026-014-8521-4 · Cited by 14
Zhang, J., Zhou, J., Ren, X., Diao, Y., Li, H., Jiang, H., Ding, K., & Pei, D. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9577-1 · Cited by 13
Galan, J. F., Germany, E., Pawlowski, A., Strickland, L. R., & Galinato, M. G. I. (2014) · The Journal of Physical Chemistry A · doi:10.1021/jp503539m · Cited by 13
Cited by
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Metadata
- Authors
- Ghosh, A. K., & Brindisi, M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-12-02
- Volume
- 63
- Issue
- 6
- Pages
- 2751-2788
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2991251974
- Cited by
- 401
- References
- 135
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.